edex_works edex_works
  • Search results for Covaxin
Image Title
covaxin-1603676480

Covaxin will soon be manufactured in Bengaluru too, Bharat Biotech seeks expansion

In April, Bharat Biotech had announced the expansion of its manufacturing capacity across multiple facilities in Hyderabad and Bengaluru to produce 700 million doses of Covaxin annually

Published on 30th June 2021
vaccine-5873170_1920

Two-year-old gets vaccine jab in UP as part of Bharat Biotech's ongoing Covaxin trials

In May, the Drugs Controller General of India (DCGI) had granted permission to Bharat Biotech to commence phase 2-3 trials of Covaxin on children as young as two

Published on 24th June 2021
coronavirus-collateral

Recruitment for clinical trial of Covaxin in 6-12 age group to start at AIIMS from June 15

The enrolment of children volunteers aged 12-18 years at the All India Institute of Medical Sciences (AIIMS) has been completed and they have been given the first dose of Covaxin

Published on 14th June 2021
covaxin-1603676480

AIIMS Delhi starts screening children aged 6 to 12 for clinical trials of Covaxin

AIIMS Patna, Mysore Medical College and Research Institute in Karnataka have also been selected to conduct clinical trials on children

Published on 14th June 2021
covaxin-1603676480

Bharat Biotech to release results of Phase 3 trials of Covaxin in July

This comes amid a raging debate on a recent pre-print study which said that while both Covaxin and Covishield showed a good immune response, Covishield produced more antibodies than Covaxin

Published on 10th June 2021
COVID-19-Vaccine-6-3

Students travelling to study abroad worried about visa cancellation over COVID vaccine shortage

Indian students who have received Covaxin or Russia's Sputnik V vaccine are being asked to inoculate again across several international institutes as these vaccines are yet to be approved by WHO

Published on 9th June 2021
covaxin-1603676480

Plea in Delhi HC seeking stay on Phase II/III clinical trial of Covaxin in 2 to 18 age group. Here's why

Fresh application seeks to stay the operation of the order of DCGI till disposal of the ongoing petition in the interest of justice

Published on 3rd June 2021
covaxin-1603676480

Covaxin batch initiated in March will only be ready for supply in June: Bharat Biotech

The manufacturing, testing, release and distribution of vaccines are complex and multi-factorial processes with hundreds of steps, requiring a diverse pool of human resources, the firm said

Published on 28th May 2021
COVID-19-Vaccine-6-3

Indian government dismisses reports that Covaxin may hamper plans to travel abroad

Multiple reports had said that over 130 countries across the globe currently accept Serum Institute of India's Covishield vaccine to enter their country while Covaxin is accepted in only nine n

Published on 22nd May 2021
covaxin-1603676480

Delhi HC seeks Centre's stand on PIL against Covaxin trial on children aged two-18 years

Covaxin, which has been indigenously developed by Bharat Biotech in collaboration with the Indian Council of Medical Research, is being used on adults

Published on 19th May 2021
covaxin-1603676480

Covaxin effective against new, emerging COVID-19 variants, says study

The study was conducted in collaboration with the National Institute of Virology and the Indian Council of Medical Research

Published on 16th May 2021
covid-19-vaccine

COVID-19: Those between 18 and 44 in Bengaluru can get vaccinated at major hospitals, med colleges from May 10

The statement said that the government has already placed orders for two crore doses of Covishield and one crore of Covaxin to vaccinate the estimated 3.26 crore people in this age group

Published on 9th May 2021
Covishield

Govt has released full advance for Covishield vaccine to SII on April 28: Health Ministry

Additionally, 100 per cent advance of Rs 787.50 crore (after TDS Rs 772.50 crore) was released on April 28 to Bharat Biotech India Ltd (BBIL) for five crore Covaxin doses during May, June and July

Published on 3rd May 2021
COVID_Vaccine_PTI

COVID-19 vaccination for people in 18-44 age group begins at some private hospitals 

Fortis Healthcare, in a statement, had said people in the 18-44 age group will be administered Covaxin for Rs 1,250, which will include the cost of vaccine and administration charges

Published on 1st May 2021
COVID_Vaccine_PTI

Bharat Biotech cuts Covaxin price for states to Rs 400 after widespread criticism

This follows a widespread criticism of its pricing policy as it sold Covaxin to the central government at Rs 150 per dose

Published on 29th April 2021

Search results 1 - 15 of 115